Neuroscience: Lack of inhibition leads to abuse.
Arthur C
AC
Riegel
Peter W
PW
Kalivas
D000818:Animals; D016739:Behavior, Addictive / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D058787:GABA-A Receptor Antagonists; D018698:Glutamic Acid / Q000378:metabolism; D007395:Interneurons / Q000187:drug effects* / Q000378:metabolism*; D051379:Mice; D008954:Models, Biological; D009020:Morphine / Q000494:pharmacology; D018091:Receptors, AMPA / Q000378:metabolism; D011963:Receptors, GABA-A / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D017557:Ventral Tegmental Area / Q000166:cytology / Q000187:drug effects / Q000378:metabolism
D058787:GABA-A Receptor Antagonists; C546241:Gabra1 protein, mouse; D018091:Receptors, AMPA; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D018698:Glutamic Acid; D009020:Morphine; D004298:Dopamine